Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity

Michael Gandy, M. Mcildowie, K. Lewis, A.M. Wasik, D. Salomonczyk, K. Wagg, Z.A. Millar, D. Tindiglia, P. Huot, T. Johnston, S. Thiele, B. Nguyen, N.M. Barnes, J.M. Brotchie, Mathew Martin-Iverson, J. Nash, J. Gordon, Matthew Piggott

Research output: Contribution to journalArticle

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)287-293
JournalMedChemComm
Volume1
Issue number4
DOIs
Publication statusPublished - 2010

Cite this

Gandy, Michael ; Mcildowie, M. ; Lewis, K. ; Wasik, A.M. ; Salomonczyk, D. ; Wagg, K. ; Millar, Z.A. ; Tindiglia, D. ; Huot, P. ; Johnston, T. ; Thiele, S. ; Nguyen, B. ; Barnes, N.M. ; Brotchie, J.M. ; Martin-Iverson, Mathew ; Nash, J. ; Gordon, J. ; Piggott, Matthew. / Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity. In: MedChemComm. 2010 ; Vol. 1, No. 4. pp. 287-293.
@article{54674f9247364a14adfe084436622fb1,
title = "Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity",
author = "Michael Gandy and M. Mcildowie and K. Lewis and A.M. Wasik and D. Salomonczyk and K. Wagg and Z.A. Millar and D. Tindiglia and P. Huot and T. Johnston and S. Thiele and B. Nguyen and N.M. Barnes and J.M. Brotchie and Mathew Martin-Iverson and J. Nash and J. Gordon and Matthew Piggott",
year = "2010",
doi = "10.1039/c0md00108b",
language = "English",
volume = "1",
pages = "287--293",
journal = "MedChemComm",
issn = "2040-2503",
publisher = "The Royal Society of Chemistry",
number = "4",

}

Gandy, M, Mcildowie, M, Lewis, K, Wasik, AM, Salomonczyk, D, Wagg, K, Millar, ZA, Tindiglia, D, Huot, P, Johnston, T, Thiele, S, Nguyen, B, Barnes, NM, Brotchie, JM, Martin-Iverson, M, Nash, J, Gordon, J & Piggott, M 2010, 'Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity' MedChemComm, vol. 1, no. 4, pp. 287-293. https://doi.org/10.1039/c0md00108b

Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity. / Gandy, Michael; Mcildowie, M.; Lewis, K.; Wasik, A.M.; Salomonczyk, D.; Wagg, K.; Millar, Z.A.; Tindiglia, D.; Huot, P.; Johnston, T.; Thiele, S.; Nguyen, B.; Barnes, N.M.; Brotchie, J.M.; Martin-Iverson, Mathew; Nash, J.; Gordon, J.; Piggott, Matthew.

In: MedChemComm, Vol. 1, No. 4, 2010, p. 287-293.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity

AU - Gandy, Michael

AU - Mcildowie, M.

AU - Lewis, K.

AU - Wasik, A.M.

AU - Salomonczyk, D.

AU - Wagg, K.

AU - Millar, Z.A.

AU - Tindiglia, D.

AU - Huot, P.

AU - Johnston, T.

AU - Thiele, S.

AU - Nguyen, B.

AU - Barnes, N.M.

AU - Brotchie, J.M.

AU - Martin-Iverson, Mathew

AU - Nash, J.

AU - Gordon, J.

AU - Piggott, Matthew

PY - 2010

Y1 - 2010

U2 - 10.1039/c0md00108b

DO - 10.1039/c0md00108b

M3 - Article

VL - 1

SP - 287

EP - 293

JO - MedChemComm

JF - MedChemComm

SN - 2040-2503

IS - 4

ER -